WuXi AppTech IPO Update: Figuring Out the Right AH Premium
WuXi AppTec Co. Ltd. (WUXI HK) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....
722 Views
Wuxi Apptec 药明康德 IPO: Welcome to the A/H Universe
WuXi Apptec is set to be the newest A/H pair with its upcoming HK listing that is set to raise USD 1 billion. The A-share (603289 CH) recorded 15...
853 Views
WuXi AppTech IPO Trading Update: What’s up with the Poor Cash Conversion?
WuXi AppTec Co. Ltd. (WUXI HK) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....
907 Views
WuXi Apptec (药明康德) IPO: This A+H Listing Will Be Different
Following a fast track A-share listing in May, WuXi AppTec is planning to raise USD 1 bn via an A+H listing. Wuxi AppTec is part of the Wuxi...
1.5k Views
WuXi AppTech IPO Preview: Pharmed Out
WuXi AppTec Co Ltd (603259 CH) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....
1.1k Views